Amgen is currently testing a new GnRH antagonist, Abarelix, for endo.
Information about Endometriosis, latest news and research.
Amgen is currently testing a new GnRH antagonist, Abarelix, for endo.
Proudly powered by WordPress | Theme: Baskerville 2 by Anders Noren.